Pharma Companies’ Disconnect Between Strategy And Execution – Part1 – Asrar Qureshi’s Blog Post #1339

The article examines how pharmaceutical companies’ growth strategies often falter when departments pursue conflicting priorities. Commercial teams seek investment and expansion, while finance and support functions focus on cost control, risk reduction, and resource limits. This disconnect causes missed opportunities, unrealistic targets, silos, weaker customer experiences, employee frustration, and poor execution.
Share